Theravance (THRX) Reports Q1 Loss of $0.09
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
Total operating expenses: 5.39M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 5.39M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Theravance (NASDAQ: THRX) reported Q1 EPS of ($0.09), versus ($0.14) reported last year. Revenue for the quarter came in at $6.8 million, versus $7 million reported last year.
For earnings history and earnings-related data on Theravance (THRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- S&P 500 may pull back before midterms, but Citi says buy the dip
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
